{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:32:32Z","timestamp":1789997552845,"version":"4.0.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,6]]},"DOI":"10.1093\/ajh\/hpx111","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T11:11:31Z","timestamp":1499425891000},"page":"1163-1169","source":"Crossref","is-referenced-by-count":60,"title":["Efficacy and Safety of Sacubitril\/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (\u226565 Years) With Systolic Hypertension"],"prefix":"10.1093","volume":"30","author":[{"given":"Ouppatham","family":"Supasyndh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2019an","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kudsia","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"key\n\t\t\t\t20171208091914_CIT0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1524-6175.2004.03606.x","article-title":"Hypertension curriculum review. The importance of systolic blood pressure elevation in elderly persons","volume":"6","year":"2004","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key\n\t\t\t\t20171208091914_CIT0002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00041552-199709000-00016","article-title":"Treatment of hypertension in the elderly","volume":"6","year":"1997","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20171208091914_CIT0003","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","article-title":"Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study","volume":"100","year":"1999","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171208091914_CIT0004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardiores.2005.01.012","article-title":"Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension","volume":"66","year":"2005","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20171208091914_CIT0005","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/archinte.1992.00400220015004","article-title":"Systolic hypertension in the elderly. Pathophysiology and management","volume":"152","year":"1992","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171208091914_CIT0006","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1161\/CIRCULATIONAHA.108.823112","article-title":"Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies","volume":"119","author":"Japan Arteriosclerosis Longitudinal Study (JALS) Group","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171208091914_CIT0007","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.265.24.3255","article-title":"Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","author":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension","year":"1991","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171208091914_CIT0008","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00004872-200304000-00013","article-title":"Blood pressure and cardiovascular disease in the Asia Pacific region","volume":"21","author":"Asia Pacific Cohort Studies Collaboration","year":"2003","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20171208091914_CIT0009","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.hjr.0000170264.84820.8e","article-title":"A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia","volume":"12","author":"Asia Pacific Cohort Studies Collaboration","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"key\n\t\t\t\t20171208091914_CIT0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s40266-013-0130-8","article-title":"Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence","volume":"30","year":"2013","journal-title":"Drugs Aging"},{"key":"key\n\t\t\t\t20171208091914_CIT0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1751-7176.2008.07460.x","article-title":"The use of olmesartan medoxomil as monotherapy or in combination with other antihypertensive agents in elderly hypertensive patients in Japan","volume":"10","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key\n\t\t\t\t20171208091914_CIT0012","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1253\/circj.CJ-13-0847","article-title":"Epidemiology of hypertension in Japan: where are we now?","volume":"77","year":"2013","journal-title":"Circ J"},{"key":"key\n\t\t\t\t20171208091914_CIT0013","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/bmj.325.7370.917","article-title":"Systolic blood pressure","volume":"325","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171208091914_CIT0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1291\/hypres.31.97","article-title":"Current status and characteristics of hypertension control in community resident elderly Korean people: data from a Korean longitudinal study on health and aging (KLoSHa study)","volume":"31","year":"2008","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20171208091914_CIT0015","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.4103\/2230-8210.86860","article-title":"Neuro-endocrine regulation of blood pressure","volume":"15","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"key\n\t\t\t\t20171208091914_CIT0016","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171208091914_CIT0017","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.CIR.97.23.2323","article-title":"Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171208091914_CIT0018","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1517\/13543784.2013.797962","article-title":"Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition","volume":"22","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20171208091914_CIT0019","first-page":"9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"key\n\t\t\t\t20171208091914_CIT0020","author":"Novartis","year":"2015"},{"key":"key\n\t\t\t\t20171208091914_CIT0021","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"PARADIGM-HF Investigators and Committees","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171208091914_CIT0022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"PARADIGM-HF Investigators and Coordinators","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171208091914_CIT0023","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171208091914_CIT0024","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.113.02002","article-title":"Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study","volume":"63","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20171208091914_CIT0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.328.7440.634","article-title":"British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary","volume":"328","author":"BHS guidelines working party, for the British Hypertension Society","year":"2004","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171208091914_CIT0026","first-page":"11","article-title":"The role of ambulatory BP monitoring in clinical care","volume":"62","year":"2007","journal-title":"Geriatrics"},{"key":"key\n\t\t\t\t20171208091914_CIT0027","first-page":"319","article-title":"Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring","volume":"4","year":"1999","journal-title":"Blood Press Monit"},{"key":"key\n\t\t\t\t20171208091914_CIT0028","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cger.2009.06.001","article-title":"Hypertension in the elderly","volume":"25","year":"2009","journal-title":"Clin Geriatr Med"},{"key":"key\n\t\t\t\t20171208091914_CIT0029","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cger.2013.05.002","article-title":"Hypertension in the elderly: unique challenges and management","volume":"29","year":"2013","journal-title":"Clin Geriatr Med"},{"key":"key\n\t\t\t\t20171208091914_CIT0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archinte.160.8.1085","article-title":"Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171208091914_CIT0031","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.HYP.32.6.983","article-title":"Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension","volume":"32","year":"1998","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20171208091914_CIT0032","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3949\/ccjm.79a.12017","article-title":"Hypertension in the elderly: some practical considerations","volume":"79","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t20171208091914_CIT0033","first-page":"S75","article-title":"The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population","volume":"11","year":"1997","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t20171208091914_CIT0034","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1751-7141.2008.00005.x","article-title":"Now or never: optimal antihypertensive therapy in the elderly","volume":"11","year":"2008","journal-title":"Prev Cardiol"},{"key":"key\n\t\t\t\t20171208091914_CIT0035","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/HJH.0b013e328352f7f6","article-title":"Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study","volume":"30","year":"2012","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20171208091914_CIT0036","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.116.08556","article-title":"Effects of sacubitril\/valsartan versus olmesartan on central hemodynamics in the elderly with systolic hypertension: The PARAMETER Study","volume":"69","year":"2017","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20171208091914_CIT0037","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/eurheartj\/ehv330","article-title":"Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF","volume":"36","author":"PARADIGM-HF Investigators and Committees","year":"2015","journal-title":"Eur Heart J"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/article-pdf\/30\/12\/1163\/22331939\/hpx111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T14:55:42Z","timestamp":1512744942000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ajh\/article\/30\/12\/1163\/3952682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,7,11]]},"published-print":{"date-parts":[[2017,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpx111","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,7,11]]}}}